Evaluating dual GLP-1 and GIP receptor agonist peptides requires rigorous lot-specific analytical verification prior to initiating preclinical protocols. PX1 Research supplies 5mg Tirzepatide with fully transparent HPLC, mass spectrometry, and endotoxin documentation for every production batch. This analytical resource details the structural parameters, verification criteria, and handling standards established for high-purity laboratory research.
Evaluating dual GLP-1 and GIP receptor agonist peptides requires rigorous lot-specific analytical verification prior to initiating preclinical protocols. PX1 Research supplies 5mg Tirzepatide with fully transparent HPLC, mass spectrometry, and endotoxin documentation for every production batch. This analytical resource details the structural parameters, verification criteria, and handling standards established for high-purity laboratory research.
A legitimate Tirzepatide COA (Certificate of Analysis) provides quantitative, independent proof of peptide purity, molecular identity, and biological safety through reverse-phase high-performance liquid chromatography (RP-HPLC), electrospray ionization mass spectrometry (ESI-MS), and bacterial endotoxin testing. For benchtop assays and preclinical research applications, each batch must demonstrate a purity threshold of ≥99.0% with a verified molecular mass matching the theoretical weight of 4813.45 Da.
When purchasing reagents for sensitive cellular or animal models, relying on unverified materials introduces substantial experimental noise. Investigators can access transparent analytical data across our entire catalog via the main research peptides hub, ensuring that every 5mg vial matches published reference specifications.
When specified as Tirzepatide – laboratory-grade. verified purity. 1 vial pack, the material is supplied in a single 5mg vacuum-sealed glass vial designed for absolute inertness and stability during long-term refrigeration or freezing. Laboratory-grade designations demand that the synthetic 39-amino-acid peptide undergoes precise solid-phase peptide synthesis (SPPS), followed by multi-stage chromatographic purification to remove residual protective groups and truncated sequence impurities.
The single-vial format allows research teams to run isolated pilot trials or smaller sample runs without exposing larger quantities of lyophilized powder to atmospheric moisture. Each 5mg unit is stoppered with pharmaceutical-grade butyl rubber seals and crimped with aluminum flip-off caps to guarantee seal integrity until reconstitution. To examine single-vial packaging options for experimental designs, visit the specific Tirzepatide 5mg product page.
To satisfy the requirements of high-impact research environments, a comprehensive Tirzepatide COA must detail several analytical metrics. Primary among these is the RP-HPLC chromatogram, which records the total area under the curve (AUC) for the main peak relative to secondary degradation peaks. A clean chromatogram confirms the absence of diastereomers, deletion sequences, and oxidized side chains.
Equally critical is mass spectrometry confirmation. Liquid chromatography-mass spectrometry (LC-MS) or matrix-assisted laser desorption/ionization (MALDI-TOF) validates the precise monoisotopic mass of the 39-amino-acid sequence containing the C20 fatty diacid moiety attached via a linker to the Lys20 residue. Finally, kinetic chromogenic Limulus Amebocyte Lysate (LAL) assays measure bacterial endotoxins, which must remain strictly below 0.5 EU/mg to prevent unspecific inflammatory interference in cell culture or in vivo models.
For a deeper examination of analytical techniques used to evaluate synthetic peptides, explore our technical documentation in the PX1 research library.
Selecting verified analytical-grade compounds over unverified market alternatives directly impacts reproducible experimental outcomes. Substandard preparations frequently suffer from peptide content variability, residual TFA (trifluoroacetic acid) salts, and elevated endotoxin levels that compromise receptor binding kinetics.
The table below outlines the minimal verification criteria required for laboratory-grade research reagents compared to standard commercial offerings:
• Purity Threshold: Laboratory-Grade requires ≥99.0% by RP-HPLC AUC; Unverified materials often measure 90.0%–95.0% or lack chromatograms. • Identity Testing: Laboratory-Grade uses ESI-MS or MALDI-TOF mass matching theoretical 4813.45 Da; Unverified materials rely on basic elemental assumptions. • Endotoxin Limits: Laboratory-Grade guarantees <0.5 EU/mg via LAL assay; Unverified materials carry unquantified endotoxin risks. • Testing Facility: Laboratory-Grade uses ISO 17025 accredited third-party laboratories; Unverified materials use in-house unaccredited self-reporting. • Traceability: Laboratory-Grade features lot-specific COA links and physical vial batch matching; Unverified materials use static, reusable PDF reports.
Within the metabolic research space, Tirzepatide represents a dual GIP/GLP-1 receptor co-agonist. Researchers comparing multi-receptor compounds to mono-agonists frequently benchmark Tirzepatide against compounds like Semaglutide 5mg, multi-target agonists like Retatrutide 5mg, or early GLP-1 analogs like Liraglutide 5mg. Understanding these baseline analytical differences ensures accurate comparative binding assays.
Proper handling during reconstitution is essential to preserve the secondary structure of Tirzepatide. Because the peptide contains a lipophilic C20 fatty diacid side chain, improper reconstitution technique or rapid agitation can cause physical aggregation or surface adsorption.
Investigators should introduce sterile bacteriostatic water or sterile phosphate-buffered saline (PBS) slowly along the internal glass wall of the vial. Direct high-velocity injection onto the lyophilized cake should be avoided to prevent foaming. Allow the diluent to fully wet the lyophilized matrix for 5–10 minutes before gently swirling the vial. Avoid mechanical vortexing. Complete detailed protocols for preparing stock solutions are available in our peptide reconstitution guide.
In its lyophilized state, Tirzepatide exhibits high thermal stability when maintained at -20°C or -80°C in a desiccated environment protected from light exposure. Under these conditions, analytical purity remains stable for up to 24 months from the date of synthesis.
Once reconstituted into aqueous solution, degradation pathways such as deamidation, methionine oxidation, and peptide bond cleavage accelerate over time. Reconstituted aliquots stored at 2°C to 8°C should be utilized within 28 days. Repeated freeze-thaw cycles must be strictly avoided as freeze-thaw stress promotes physical precipitation and loss of functional concentration. Review our published guidelines on lyophilization and storage for additional shelf-life optimization strategies.
Preclinical studies indicate that Tirzepatide functions as an engineered peptide heterodimer surrogate acting as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Structural biology data demonstrate that its sequence is derived from the native GIP sequence, modified with C-terminal amino acids from exendin-4 and an engineered C20 fatty diacid acyl chain.
In vitro functional assays report that Tirzepatide exhibits balanced potent activity at the GIP receptor while showing biased signaling at the GLP-1 receptor relative to native GLP-1. Rodent metabolic models evaluating intracellular cyclic AMP (cAMP) accumulation show enhanced signaling dynamics that differ substantially from selective single-receptor agonists such as those detailed in our overview of GLP-1 receptor agonists.
To protect peptide stability against environmental degradation during transit, PX1 Research enforces strict domestic fulfillment standards. All compounds are manufactured in US-based, GMP-compliant facilities and tested in ISO 17025 accredited laboratories before release.
Orders are dispatched same-day Monday through Friday from centralized distribution centers located in California and Arizona. This minimizes transit times and limits ambient temperature exposure during shipping. Institutional buyers setting up recurring procurement orders or high-volume studies can establish custom laboratory accounts through our dedicated wholesale division.
What is documented on a standard Tirzepatide COA?
A standard Tirzepatide COA includes batch identity, chemical formula (C225H348N48O68), theoretical molecular weight (4813.45 Da), RP-HPLC purity percentage (AUC), ESI-MS molecular weight verification, residual solvent analysis, and LAL endotoxin testing results.
Where can I download the Tirzepatide COA for my specific batch?
Batch-specific COA documents are accessible directly through the PX1 Research portal by searching the lot number printed on your vial label, or on the dedicated Tirzepatide 5mg product page.
What does tirzepatide – laboratory-grade. verified purity. 1 vial pack signify?
This designation indicates a single 5mg vacuum-sealed vial of synthetic Tirzepatide that has undergone rigorous third-party analytical testing to confirm ≥99.0% RP-HPLC purity and structural identity for preclinical laboratory research.
What HPLC purity threshold is required for Tirzepatide in cell culture models?
Preclinical and cell culture research protocols typically require a minimum purity threshold of ≥98.0% to ≥99.0% by RP-HPLC to prevent unintended cellular responses caused by peptide synthesis byproducts or truncated sequences.
How is mass spectrometry used to verify Tirzepatide molecular identity?
Electrospray ionization mass spectrometry (ESI-MS) measures the mass-to-charge ratio of the compound, confirming that the observed molecular mass matches the theoretical mass of 4813.45 Da, including the intact C20 fatty acid side chain.
What are the acceptable endotoxin limits for Tirzepatide in preclinical studies?
For reliable in vitro assays and rodent models, bacterial endotoxins measured via kinetic chromogenic LAL testing must remain strictly below 0.5 EU/mg to prevent non-specific macrophage activation.
How should a 5mg vial of Tirzepatide be reconstituted for benchtop assays?
Reconstitution should be performed using sterile bacteriostatic water or sterile PBS. Gently direct the fluid down the side of the vial wall and allow it to self-dissolve with light swirling. Avoid vigorous shaking or mechanical vortexing.
What is the shelf life of lyophilized Tirzepatide 5mg stored at -20°C?
When stored sealed in a desiccated freezer environment at -20°C or below, lyophilized Tirzepatide maintains analytical stability and purity for up to 24 months from the date of manufacture.
How does Tirzepatide compare to Semaglutide in dual-receptor binding assays?
In vitro binding assays indicate that Tirzepatide activates both GIP and GLP-1 receptors, whereas Semaglutide acts selectively on GLP-1 receptors. Dual receptor activation often produces distinct cAMP accumulation patterns in receptor-expressing cell lines.
What shipping protocols are used to preserve peptide integrity during transit?
PX1 Research dispatches orders same-day Monday through Friday from California and Arizona facilities using temperature-controlled packaging materials designed to minimize heat exposure during transit.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.